Table 2. Interrelation of CRP/alb ratio with clinicopathological characteristics (n=40).
| Characteristic | CRP/alb ≤0.085 | CRP/alb >0.085 | P-value |
|---|---|---|---|
| Sex | 0.072 | ||
| Male | 21 | 6 | |
| Female | 6 | 7 | |
| Mean age (yr) | 64.3 | 63.5 | 0.932 |
| TNM stage | 0.002* | ||
| I | 9 | 1 | |
| II | 7 | 0 | |
| III | 5 | 1 | |
| IV | 6 | 11 | |
| T stage | |||
| T1 | 10 | 1 | 0.002* |
| T2 | 8 | 0 | |
| T3 | 3 | 2 | |
| T4 | 6 | 10 | |
| N stage | 0.006* | ||
| N0 | 24 | 6 | |
| N1 | 3 | 7 | |
| N2 | 0 | 0 | |
| N3 | 0 | 0 | |
| M stage | 0.029* | ||
| M0 | 27 | 10 | |
| M1 | 0 | 3 | |
| Mean tumor size (cm) | 2.4 | 3.4 | 0.029* |
| Degree of differentiation | 0.386 | ||
| In situ | 0 | 1 | |
| Well | 15 | 9 | |
| Moderately | 11 | 3 | |
| Poorly | 1 | 0 | |
| Mean PNI | 53.41 | 47.96 | 0.002* |
| Mean NLR | 1.93 | 1.94 | 0.711 |
| Mean PLR | 0125.14 | 0130.87 | 0.568 |
| Mean WBC | 6.32 | 6.70 | 0.407 |
| mGPS | 0.029* | ||
| 0 | 27 | 10 | |
| 1 | 0 | 2 | |
| 2 | 0 | 1 |
(CRP/alb: C-reactive protein/albumin, PNI: prognostic nutritional index, NLR: neutrophil-lymphocyte ratio, PLR: platelet-lymphocyte ratio, WBC: white blood cell count, mGPS: modified Glasgow Prognostic Score)
*P<0.05.
Values are presented as number of patients or mean.